At a glance
- Originator Lundbeck A/S
- Class Anxiolytics; Piperazines; Small molecules; Spiro compounds
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 23 May 1995 Discontinued-Preclinical for Anxiety disorders in Denmark (Unknown route)